Dermatofibrosarcoma Protuberans: A Partial Response to Imatinib Therapy
- 31 March 2006
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Dermatologic Surgery
- Vol. 32 (3), 456-459
- https://doi.org/10.1111/j.1524-4725.2006.32090.x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Genetics of dermatofibrosarcoma protuberans family of tumors: From ring chromosomes to tyrosine kinase inhibitor treatmentGenes, Chromosomes and Cancer, 2003
- Pharmacology of imatinib (STI571)European Journal of Cancer, 2002
- Molecular Targeting of Platelet-Derived Growth Factor B by Imatinib Mesylate in a Patient With Metastatic Dermatofibrosarcoma ProtuberansJournal of Clinical Oncology, 2002
- Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberansInternational Journal of Cancer, 2002
- Growth-inhibitory effect of STI571 on cells transformed by the COL1A1/PDGFB rearrangement.International Journal of Cancer, 2001
- Dermatofibrosarcoma protuberansJournal of the American Academy of Dermatology, 1996
- Fibrosarcomatous Change in Dermatofibrosarcoma ProtuberansThe American Journal of Surgical Pathology, 1988
- Dermatofibrosarcoma ProtuberansAnnals of Surgery, 1967
- Dermatofibrosarcoma protuberansPlastic and Reconstructive Surgery, 1962